327 related articles for article (PubMed ID: 16362986)
1. Rational design of gene-based vaccines.
Barouch DH
J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
[TBL] [Abstract][Full Text] [Related]
2. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses.
Barouch DH; Letvin NL; Seder RA
Immunol Rev; 2004 Dec; 202():266-74. PubMed ID: 15546399
[TBL] [Abstract][Full Text] [Related]
3. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.
Seregin SS; Amalfitano A
Expert Opin Biol Ther; 2009 Dec; 9(12):1521-31. PubMed ID: 19780714
[TBL] [Abstract][Full Text] [Related]
4. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
Spreng S; Viret JF
Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenoviruses as vaccines.
Randrianarison-Jewtoukoff V; Perricaudet M
Biologicals; 1995 Jun; 23(2):145-57. PubMed ID: 7546657
[TBL] [Abstract][Full Text] [Related]
8. [Immunity and EGFPC3 expression of recombinant attenuated salmonella typhimurium carrying plasmid pcDNA3s and EGFPC3 in mice].
Fang XX; Wang DM; Shi YH; LE GW; Bai XP; Liu JW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):299-302. PubMed ID: 17428380
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines: vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
[TBL] [Abstract][Full Text] [Related]
10. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
12. From plasmids to protection: a review of DNA vaccines against infectious diseases.
Laddy DJ; Weiner DB
Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.
Takeda A; Igarashi H; Kawada M; Tsukamoto T; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Matano T
Vaccine; 2008 Dec; 26(52):6839-43. PubMed ID: 18930099
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines.
Donnelly JJ; Ulmer JB; Shiver JW; Liu MA
Annu Rev Immunol; 1997; 15():617-48. PubMed ID: 9143702
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
Ning JF; Zhu W; Xu JP; Zheng CY; Meng XL
Vaccine; 2009 Feb; 27(7):1127-35. PubMed ID: 19071178
[TBL] [Abstract][Full Text] [Related]
16. T-cell immunity generated by recombinant adenovirus vaccines.
Yang TC; Millar JB; Grinshtein N; Bassett J; Finn J; Bramson JL
Expert Rev Vaccines; 2007 Jun; 6(3):347-56. PubMed ID: 17542750
[TBL] [Abstract][Full Text] [Related]
17. In vitro assay of immunostimulatory activities of plasmid vectors.
Jiang W; Reich CF; Pisetsky DS
Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
[TBL] [Abstract][Full Text] [Related]
18. Design of plasmid DNA constructs for vaccines.
Montgomery DL; Prather KJ
Methods Mol Med; 2006; 127():11-22. PubMed ID: 16988443
[TBL] [Abstract][Full Text] [Related]
19. Targeting plasmid-encoded proteins to the antigen presentation pathways.
Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
[TBL] [Abstract][Full Text] [Related]
20. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
